title: Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study.
authors: Ankara Education and Research Hospital, Gastroenterology, Ankara, Turkey. Electronic address: bilalergul@gmail.com.
authors: Bilal
authors: B
authors: Ergül
authors: Erdem
authors: E
authors: Koçak
authors: Adnan
authors: A
authors: Taş
authors: Levent
authors: L
authors: Filik
authors: Seyfettin
authors: S
authors: Köklü
mesh_terms: D000328:Adult; D000368:Aged; D000863:Antacids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D016099:Endoscopy, Gastrointestinal; D005260:Female; D024841:Fluoroquinolones; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D064747:Lansoprazole / Q000627:therapeutic use*; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D000077266:Moxifloxacin; D009942:Organometallic Compounds / Q000627:therapeutic use*; D011446:Prospective Studies; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000863:Antacids; D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D009942:Organometallic Compounds; D054328:Proton Pump Inhibitors; D011804:Quinolines; D064747:Lansoprazole; D013752:Tetracycline; C002791:bismuth tripotassium dicitrate; D000077266:Moxifloxacin